Anti-IL34/ C16orf77/ IL-34 functional antibody

Anti-IL34/ C16orf77/ IL-34 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to IL34/IL34 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1028-Ab-1/ GM-Tg-hg-SE1028-Ab-2Anti-Human IL34 monoclonal antibodyHuman
GM-Tg-rg-SE1028-Ab-1/ GM-Tg-rg-SE1028-Ab-2Anti-Rat IL34 monoclonal antibodyRat
GM-Tg-mg-SE1028-Ab-1/ GM-Tg-mg-SE1028-Ab-2Anti-Mouse IL34 monoclonal antibodyMouse
GM-Tg-cynog-SE1028-Ab-1/ GM-Tg-cynog-SE1028-Ab-2Anti-Cynomolgus/ Rhesus macaque IL34 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1028-Ab-1/ GM-Tg-felg-SE1028-Ab-2Anti-Feline IL34 monoclonal antibodyFeline
GM-Tg-cang-SE1028-Ab-1/ GM-Tg-cang-SE1028-Ab-2Anti-Canine IL34 monoclonal antibodyCanine
GM-Tg-bovg-SE1028-Ab-1/ GM-Tg-bovg-SE1028-Ab-2Anti-Bovine IL34 monoclonal antibodyBovine
GM-Tg-equg-SE1028-Ab-1/ GM-Tg-equg-SE1028-Ab-2Anti-Equine IL34 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1028-Ab-1/ GM-Tg-hg-SE1028-Ab-2; GM-Tg-rg-SE1028-Ab-1/ GM-Tg-rg-SE1028-Ab-2;
GM-Tg-mg-SE1028-Ab-1/ GM-Tg-mg-SE1028-Ab-2; GM-Tg-cynog-SE1028-Ab-1/ GM-Tg-cynog-SE1028-Ab-2;
GM-Tg-felg-SE1028-Ab-1/ GM-Tg-felg-SE1028-Ab-2; GM-Tg-cang-SE1028-Ab-1/ GM-Tg-cang-SE1028-Ab-2;
GM-Tg-bovg-SE1028-Ab-1/ GM-Tg-bovg-SE1028-Ab-2; GM-Tg-equg-SE1028-Ab-1/ GM-Tg-equg-SE1028-Ab-2
Products NameAnti-IL34 monoclonal antibody
Formatmab
Target NameIL34
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IL34 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1028-Ag-1Recombinant multi-species IL34/ C16orf77/ IL-34 protein
    ORF Viral VectorpGMLV000372human IL34 Lentivirus plasmid
    ORF Viral VectorvGMLV000372human IL34 Lentivirus particle


    Target information

    Target IDGM-SE1028
    Target NameIL34
    Gene ID146433,76527,498951,709034,610536,101094391,508292,100054703
    Gene Symbol and Synonyms2010004A03Rik,C16orf77,C18H16ORF77,IL-34,IL34
    Uniprot AccessionQ6ZMJ4,Q4KM46,A6QL48
    Uniprot Entry NameIL34_HUMAN,IL34_RAT,IL34_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000157368
    Target ClassificationN/A

    The target: IL34, gene name: IL34, also named as C16orf77, IL-34. Interleukin-34 is a cytokine that promotes the differentiation and viability of monocytes and macrophages through the colony-stimulating factor-1 receptor (CSF1R; MIM 164770) (Lin et al., 2008 [PubMed 18467591]).[supplied by OMIM, May 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.